Locaible vs Owkin

Locaible and Owkin are both ai agent apps tracked by AIDiveForge. Below is a side-by-side comparison of pricing, capabilities, platforms, and ownership — sourced from each tool's live website and verified before publishing.

Locaible

Locaible runs AI agents entirely on your own machine: no bytes leave the device, no API calls to OpenAI or Anthropic, no telemetry. The vendor states it is GDPR and EU AI Act compliant by design, which matters when your legal or finance team needs a paper trail for the regulator, not a ToS URL. Multi-step workflows chain separate agents — one retrieves from your indexed documents, one analyses, one drafts — each running its own local model. The ceiling appears when your team scales beyond a small LAN setup: team seats authenticate over a private token and require a detected LAN IP, so distributed or remote teams hit a networking configuration wall before they hit a workflow one.

Owkin

K Pro is an agentic AI scientist from Owkin that autonomously traverses multimodal biomedical data — genomics, spatial multi-omics, clinical trial records, competitive intelligence — and returns ranked, evidence-grounded answers to R&D questions. The vendor states it is trained on a proprietary multimodal patient data network and continuously refined by oncologists and biologists, which means its outputs are not generic literature summaries but claims tied to patient-level evidence. For target identification or patient stratification questions, that grounding matters. Where it breaks: teams that need to interrogate their own proprietary assay data or internal compound libraries will hit the edges of what K Pro's data network covers. The platform is not self-hosted, so data residency requirements that block cloud-based analysis force a different architecture entirely.

Attribute	Locaible	Owkin
Pricing	Paid	Paid
Price	—	Custom (contact vendor)
Free trial	7 days	180 days
Open source	No	No
Has API	Yes	Yes
Self-hosted option	Yes	No
Platforms	Windows, macOS, Linux	Web-based SaaS; available on AWS Marketplace
Released	—	2025-05
Pros	All inference and document indexing runs on your own machine with zero bytes sent to external APIs, which means sensitive legal, medical, or financial documents never appear in a third-party audit log or training dataset. GDPR and EU AI Act compliance is built into the architecture rather than configured after the fact, so your compliance team gets a defensible data-flow diagram instead of a vendor's promise. Multi-agent chains assign separate models to search, analysis, and drafting steps, so you can run a lighter model for retrieval and reserve a heavier one for synthesis — keeping hardware costs proportional to task complexity. An OpenAI-compatible local API at 127.0.0.1 means tools already pointed at the OpenAI endpoint can redirect to Locaible with a one-line config change, avoiding a rewrite of existing scripts or integrations. Per-agent satisfaction ratings and a feedback loop let teams improve agent behaviour incrementally without sending prompt history or document content anywhere, so iteration stays inside your security perimeter.	Autonomous multi-step traversal of multimodal biomedical data — genomics, spatial biology, clinical records — so a target identification question that previously required a cross-functional team pulling data from separate systems returns as a ranked, evidence-backed report instead of a week-long sprint. Spatial multi-omics reporting built into the platform, which means tissue-context hypotheses that flat transcriptomic pipelines cannot express are answerable without standing up a separate analysis stack. Continuous refinement by a network of oncologists and biologists, so outputs carry domain validation rather than raw model outputs that a biology team must re-evaluate from scratch before trusting. API access available, so engineering teams can route K Pro's outputs into existing portfolio tracking or data warehouse pipelines rather than treating it as a standalone dashboard. A free-tier evaluation path, so a team can run real R&D questions against the platform before committing budget — avoiding the demo-looks-great, production-fails pattern that has burned previous tool adoptions.
Cons	Team seats authenticate via a LAN IP detected from the host machine running Ollama — the moment a team member is remote, on a VPN with a different subnet, or on a separate office network, seat connectivity breaks and requires manual network configuration that the product does not automate. The agent Marketplace and multi-agent chaining are designed for use cases where all data stays local; any workflow that needs to pull from an external SaaS API (a live CRM, an external database, a third-party webhook) has no native cloud connector, so teams build a custom integration layer or abandon Locaible for a cloud-native agent platform that ships those connectors out of the box. Hardware requirements are carried entirely by the host machine — running a 14B-parameter analysis model alongside an 8B retrieval model and an 8B drafting model in parallel taxes consumer laptop RAM and GPU memory quickly, and the docs describe no offloading or distributed inference option, which means teams with heavier document volumes need to provision dedicated on-premises hardware before the workflow is production-stable.	Any question that depends on internal, unpublished compound data or proprietary assay results hits a hard wall: K Pro has no self-hosted option and no documented mechanism for ingesting datasets that cannot leave a team's infrastructure. Regulated pharma teams with data residency mandates are blocked entirely and evaluate federated or on-premise alternatives. The platform's strength is questions answerable from population-level biomedical evidence. Mechanistic hypotheses that require wet lab iteration loops beyond what Owkin's own infrastructure supports are not addressable through the tool alone — teams still need to maintain a separate experimental validation pipeline, which means K Pro becomes one input in a larger workflow rather than the workflow itself. Enterprise pricing is custom and opaque; teams cannot size budget against usage until they engage Owkin's sales process. For smaller biotech teams where procurement cycles are slow and headcount for vendor negotiation is limited, this blocks a fast build-vs-buy decision and pushes some teams toward academic or open-source tooling with predictable cost structures.

Bottom line

Locaible and Owkin are closely matched on pricing model, openness, and API availability — pick by feature set and platform support in the table above.

Frequently asked questions

What is the difference between Locaible and Owkin?

Locaible is Paid, while Owkin is Paid. Compare pricing, free trial, API, platforms, and pros/cons in the table above on AIDiveForge.

Is Locaible better than Owkin?

It depends on your workflow. Use the side-by-side attributes (pricing, open source, API, self-hosted, platforms) to decide. AIDiveForge does not rank a universal winner — we publish verified facts so you can choose.